TWD 52.1
(-1.14%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 26.78 Billion TWD | -3.27% |
2022 | 27.69 Billion TWD | 3.65% |
2021 | 26.71 Billion TWD | 6.7% |
2020 | 25.03 Billion TWD | 0.42% |
2019 | 24.93 Billion TWD | -2.67% |
2018 | 25.61 Billion TWD | -1.72% |
2017 | 26.06 Billion TWD | -0.19% |
2016 | 26.11 Billion TWD | -5.17% |
2015 | 27.53 Billion TWD | 52.1% |
2014 | 18.1 Billion TWD | 14.92% |
2013 | 15.75 Billion TWD | 12.44% |
2012 | 14.01 Billion TWD | -1.28% |
2011 | 14.19 Billion TWD | -2.29% |
2010 | 14.52 Billion TWD | 21.36% |
2009 | 11.96 Billion TWD | -14.36% |
2008 | 13.97 Billion TWD | 13.21% |
2007 | 12.34 Billion TWD | -1.28% |
2006 | 12.5 Billion TWD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 29.18 Billion TWD | 8.54% |
2024 Q1 | 26.89 Billion TWD | 0.39% |
2023 FY | 26.78 Billion TWD | -3.27% |
2023 Q1 | 27.87 Billion TWD | 0.66% |
2023 Q3 | 27.02 Billion TWD | -9.06% |
2023 Q4 | 26.78 Billion TWD | -0.88% |
2023 Q2 | 29.71 Billion TWD | 6.61% |
2022 Q2 | 31.06 Billion TWD | 4.47% |
2022 Q4 | 27.69 Billion TWD | -0.3% |
2022 Q1 | 29.74 Billion TWD | 11.32% |
2022 FY | 27.69 Billion TWD | 3.65% |
2022 Q3 | 27.77 Billion TWD | -10.6% |
2021 Q3 | 25.04 Billion TWD | -0.69% |
2021 FY | 26.71 Billion TWD | 6.7% |
2021 Q1 | 25.15 Billion TWD | 0.47% |
2021 Q4 | 26.71 Billion TWD | 6.65% |
2021 Q2 | 25.22 Billion TWD | 0.27% |
2020 Q4 | 25.03 Billion TWD | -0.14% |
2020 Q3 | 25.07 Billion TWD | -6.78% |
2020 Q2 | 26.89 Billion TWD | 6.25% |
2020 Q1 | 25.31 Billion TWD | 1.53% |
2020 FY | 25.03 Billion TWD | 0.42% |
2019 Q2 | 27.91 Billion TWD | 5.88% |
2019 FY | 24.93 Billion TWD | -2.67% |
2019 Q4 | 24.93 Billion TWD | -3.02% |
2019 Q3 | 25.7 Billion TWD | -7.9% |
2019 Q1 | 26.36 Billion TWD | 2.91% |
2018 Q2 | 28.05 Billion TWD | 6.24% |
2018 Q3 | 26.48 Billion TWD | -5.61% |
2018 FY | 25.61 Billion TWD | -1.72% |
2018 Q1 | 26.4 Billion TWD | 1.32% |
2018 Q4 | 25.61 Billion TWD | -3.26% |
2017 Q3 | 26.54 Billion TWD | -5.61% |
2017 Q4 | 26.06 Billion TWD | -1.81% |
2017 FY | 26.06 Billion TWD | -0.19% |
2017 Q1 | 26.12 Billion TWD | 0.04% |
2017 Q2 | 28.12 Billion TWD | 7.65% |
2016 Q2 | 28.4 Billion TWD | 6.5% |
2016 FY | 26.11 Billion TWD | -5.17% |
2016 Q4 | 26.11 Billion TWD | -1.73% |
2016 Q3 | 26.57 Billion TWD | -6.44% |
2016 Q1 | 26.66 Billion TWD | -3.15% |
2015 FY | 27.53 Billion TWD | 52.1% |
2015 Q2 | 17.11 Billion TWD | 5.03% |
2015 Q1 | 16.29 Billion TWD | -10.02% |
2015 Q3 | 29.5 Billion TWD | 72.42% |
2015 Q4 | 27.53 Billion TWD | -6.66% |
2014 Q1 | 15.95 Billion TWD | 1.28% |
2014 Q3 | 19.06 Billion TWD | 5.68% |
2014 Q2 | 18.04 Billion TWD | 13.07% |
2014 FY | 18.1 Billion TWD | 14.92% |
2014 Q4 | 18.1 Billion TWD | -5.04% |
2013 Q3 | 15.57 Billion TWD | -13.89% |
2013 Q4 | 15.75 Billion TWD | 1.15% |
2013 FY | 15.75 Billion TWD | 12.44% |
2013 Q1 | 15.74 Billion TWD | 12.4% |
2013 Q2 | 18.08 Billion TWD | 14.85% |
2012 FY | 14.01 Billion TWD | -1.28% |
2012 Q4 | 14.01 Billion TWD | -2.02% |
2012 Q1 | 13.92 Billion TWD | -1.86% |
2012 Q3 | 14.3 Billion TWD | -15.71% |
2012 Q2 | 16.96 Billion TWD | 21.81% |
2011 Q4 | 14.19 Billion TWD | -10.92% |
2011 Q1 | 15.43 Billion TWD | 6.29% |
2011 FY | 14.19 Billion TWD | -2.29% |
2011 Q3 | 15.93 Billion TWD | -10.33% |
2011 Q2 | 17.76 Billion TWD | 15.09% |
2010 Q4 | 14.52 Billion TWD | 0.0% |
2010 FY | 14.52 Billion TWD | 21.36% |
2009 FY | 11.96 Billion TWD | -14.36% |
2008 FY | 13.97 Billion TWD | 13.21% |
2007 FY | 12.34 Billion TWD | -1.28% |
2006 FY | 12.5 Billion TWD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Sinon Corporation | 6.79 Billion TWD | -294.064% |
All Cosmos Bio-Tech Holding Corporation | 859.54 Million TWD | -3016.32% |
CH Biotech R&D Co., Ltd. | 1.12 Billion TWD | -2272.416% |